{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:15:00Z","timestamp":1762078500607,"version":"build-2065373602"},"reference-count":7,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,3,27]],"date-time":"2003-03-27T00:00:00Z","timestamp":1048723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2003,4]]},"abstract":"<jats:p>Objective.\u2014To evaluate the effectiveness of sumatriptan 20 mg via nasal spray and 100\u2010mg tablets in treating migrainous headache in patients without a concomitant migraine diagnosis.<\/jats:p>\n                  <jats:p>Methods.\u2014We prospectively investigated the efficacy of sumatriptan 20 mg via nasal spray and 100\u2010mg tablets in patients with a history of at least 5 moderate to severe headache attacks lasting 2 to 72 hours that consistently did not meet the International Headache Society (IHS) criteria for migraine or episodic tension\u2010type headache.<\/jats:p>\n                  <jats:p>Results.\u2014Nineteen headache attacks classifiable as migrainous disorder without aura (IHS 1.7) were evaluated in 13 patients using 20\u2010mg sumatriptan nasal spray within a 10\u2010week period. A 2\u2010point decrease in headache severity on a four\u2010point scale was achieved in 74% (95% confidence interval [CI], 50% to 89%) of the attacks within 2 hours. The pain\u2010free incidence (a reduction in headache severity from moderate or severe to none) was 37% (95% CI, 17% to 63%) after 2 hours. Ten patients completed the second part of the study, taking oral sumatriptan for 14 migrainous attacks: a 2\u2010point decrease in headache severity was achieved in 38% (95% CI, 13% to 71%) of the attacks within 2 hours and in 77% (95% CI, 48% to 92%) within 4 hours.<\/jats:p>\n                  <jats:p>Conclusion.\u2014This is the first prospective study to show that intranasal or oral sumatriptan may be effective in patients experiencing moderate to severe headache attacks which consistently do not fulfill the IHS criteria for migraine or episodic tension\u2010type headache.<\/jats:p>","DOI":"10.1046\/j.1526-4610.2003.03075.x","type":"journal-article","created":{"date-parts":[[2004,1,27]],"date-time":"2004-01-27T09:13:52Z","timestamp":1075194832000},"page":"395-399","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Sumatriptan Nasal Spray in Recurrent Migrainous Headache: An Open Prospective Study"],"prefix":"10.1111","volume":"43","author":[{"given":"J. A.","family":"Carpay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. H. J. P.","family":"Linssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J. J.","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. R.","family":"Arends","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. G. M.","family":"Tiedink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,3,27]]},"reference":[{"issue":"7","key":"e_1_2_7_2_2","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain.","volume":"8","author":"Headache Classification Committee of the International Headache Society","year":"1988","journal-title":"Cephalalgia"},{"key":"e_1_2_7_3_2","first-page":"511","article-title":"NHG\u2010Standard migraine (eerste herziening).","volume":"42","author":"Bartelink ME","year":"1999","journal-title":"Huisarts Wetenschap"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1997.1705588.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2000.00143.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.1996.tb00184.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199855060-00020"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1996.1606431.x"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1526-4610.2003.03075.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1526-4610.2003.03075.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:34:49Z","timestamp":1762072489000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1046\/j.1526-4610.2003.03075.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,27]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["10.1046\/j.1526-4610.2003.03075.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1526-4610.2003.03075.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"type":"print","value":"0017-8748"},{"type":"electronic","value":"1526-4610"}],"subject":[],"published":{"date-parts":[[2003,3,27]]}}}